Samuel Zalipsky
- Molecular Biology top 2%
- Biomaterials top 0.1%
- Biomedical Engineering top 2%
- Organic Chemistry top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Alberto GabizónTheresa M. AllenAviva T. HorowitzDorit GorenHilary ShmeedaMartin C. WoodleNasreen MullahCharles Engbers
- Topics
- Nanoparticle-Based Drug Delivery (26 papers)RNA Interference and Gene Delivery (25 papers)Lipid Membrane Structure and Behavior (11 papers)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Samuel Zalipsky
60 papers receiving 6.4k citations
Peers
Comparison fields: 5 of 136
- Molecular Biology 3.9k
- Biomaterials 3.3k
- Biomedical Engineering 1.5k
- Organic Chemistry 1.2k
- Radiology, Nuclear Medicine and Imaging 914
Countries citing papers authored by Samuel Zalipsky
This map shows the geographic impact of Samuel Zalipsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Zalipsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Zalipsky more than expected).
Fields of papers citing papers by Samuel Zalipsky
This network shows the impact of papers produced by Samuel Zalipsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Zalipsky. The network helps show where Samuel Zalipsky may publish in the future.
Co-authorship network of co-authors of Samuel Zalipsky
This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Zalipsky. A scholar is included among the top collaborators of Samuel Zalipsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Zalipsky. Samuel Zalipsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 99 | |
| 5 | 63 | |
| 6 | 68 | |
| 7 | 219 | |
| 8 | 12 | |
| 9 | Folate receptor targeting of pegylated liposomal cisplatin enhances anti-tumor activity in mouse models without increasing toxicity | 2 |
| 10 | 179 | |
| 11 | 66 | |
| 12 | 7 | |
| 13 | 154 | |
| 14 | 63 | |
| 15 | 47 | |
| 16 | 251 | |
| 17 | 1 | |
| 18 | 283 | |
| 19 | 41 | |
| 20 | 66 |
About Samuel Zalipsky
Samuel Zalipsky is a scholar working on Biomaterials, Molecular Biology and Surfaces, Coatings and Films, having authored 60 papers that have together received 6.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (26 papers), RNA Interference and Gene Delivery (25 papers) and Lipid Membrane Structure and Behavior (11 papers). The work is most often cited by research in Biomaterials (3.3k citations), Surfaces, Coatings and Films (503 citations) and Pharmaceutical Science (382 citations). Samuel Zalipsky has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Alberto Gabizón, Theresa M. Allen, Aviva T. Horowitz, Dorit Goren, Hilary Shmeeda, Martin C. Woodle, Nasreen Mullah, Charles Engbers, Christian Hansen and Dina Tzemach. Their work appears in journals such as Science, Journal of the American Chemical Society and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.